Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7578 | 1272 | 36.5 | 65% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
332 | 17329 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | C1Q | Author keyword | 43 | 34% | 8% | 102 |
2 | C1Q DEFICIENCY | Author keyword | 25 | 75% | 1% | 18 |
3 | ANTI C1Q ANTIBODIES | Author keyword | 23 | 76% | 1% | 16 |
4 | ANTI C1Q AUTOANTIBODIES | Author keyword | 15 | 73% | 1% | 11 |
5 | C1Q RECEPTORS | Author keyword | 11 | 100% | 0% | 6 |
6 | ENZYMOL MOL | Address | 10 | 35% | 2% | 24 |
7 | CD93 | Author keyword | 9 | 64% | 1% | 9 |
8 | ANTI C1Q ANTIBODY | Author keyword | 9 | 83% | 0% | 5 |
9 | HABP1 | Author keyword | 8 | 70% | 1% | 7 |
10 | ANTI C1Q | Author keyword | 7 | 53% | 1% | 10 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | C1Q | 43 | 34% | 8% | 102 | Search C1Q | Search C1Q |
2 | C1Q DEFICIENCY | 25 | 75% | 1% | 18 | Search C1Q+DEFICIENCY | Search C1Q+DEFICIENCY |
3 | ANTI C1Q ANTIBODIES | 23 | 76% | 1% | 16 | Search ANTI+C1Q+ANTIBODIES | Search ANTI+C1Q+ANTIBODIES |
4 | ANTI C1Q AUTOANTIBODIES | 15 | 73% | 1% | 11 | Search ANTI+C1Q+AUTOANTIBODIES | Search ANTI+C1Q+AUTOANTIBODIES |
5 | C1Q RECEPTORS | 11 | 100% | 0% | 6 | Search C1Q+RECEPTORS | Search C1Q+RECEPTORS |
6 | CD93 | 9 | 64% | 1% | 9 | Search CD93 | Search CD93 |
7 | ANTI C1Q ANTIBODY | 9 | 83% | 0% | 5 | Search ANTI+C1Q+ANTIBODY | Search ANTI+C1Q+ANTIBODY |
8 | HABP1 | 8 | 70% | 1% | 7 | Search HABP1 | Search HABP1 |
9 | ANTI C1Q | 7 | 53% | 1% | 10 | Search ANTI+C1Q | Search ANTI+C1Q |
10 | HYALURONAN BINDING PROTEIN 1 | 6 | 80% | 0% | 4 | Search HYALURONAN+BINDING+PROTEIN+1 | Search HYALURONAN+BINDING+PROTEIN+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLQ | 91 | 60% | 8% | 99 |
2 | 1ST COMPONENT | 88 | 51% | 10% | 122 |
3 | COMPLEMENT SUBCOMPONENT C1Q | 62 | 92% | 2% | 24 |
4 | GLOBULAR HEADS | 57 | 62% | 5% | 59 |
5 | COLLAGEN LIKE REGION | 54 | 49% | 6% | 81 |
6 | P 32 PROTEIN | 38 | 69% | 3% | 33 |
7 | SUBCOMPONENT C1Q | 34 | 56% | 3% | 41 |
8 | C1Q RECEPTOR | 28 | 60% | 2% | 31 |
9 | C1Q MEDIATED ENHANCEMENT | 27 | 76% | 1% | 19 |
10 | A CHAINS | 25 | 70% | 2% | 21 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Anti-C1q autoantibodies, novel tests, and clinical consequences | 2013 | 8 | 57 | 81% |
THE CLASSICAL COMPLEMENT PATHWAY - ACTIVATION AND REGULATION OF THE 1ST COMPLEMENT COMPONENT | 1985 | 366 | 79 | 72% |
Structure and activation of the C1 complex of complement: unraveling the puzzle | 2004 | 99 | 36 | 61% |
Complement and non-complement activating functions of C1q: A prototypical innate immune molecule | 2012 | 16 | 128 | 47% |
Complement component C1q and anti-C1q antibodies in theory and in clinical practice | 2008 | 20 | 48 | 75% |
The classical and regulatory functions of C1q in immunity and autoimmunity | 2008 | 51 | 109 | 40% |
gClq-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection | 2001 | 89 | 64 | 53% |
The complement system in systemic lupus erythematosus: an update | 2014 | 11 | 102 | 24% |
Complement, interferon and lupus | 2012 | 18 | 46 | 35% |
ACTIVATION OF THE 1ST COMPONENT OF COMPLEMENT | 1987 | 118 | 66 | 77% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ENZYMOL MOL | 10 | 35% | 1.9% | 24 |
2 | UNIV HOSP QUEEN GIOVANNA | 4 | 75% | 0.2% | 3 |
3 | ENZYMOL MOL BIOL STRUCT JEAN PIERRE EBEL | 3 | 100% | 0.2% | 3 |
4 | BIOCHEM MOL MED NUTRIGEN | 3 | 60% | 0.2% | 3 |
5 | BIOL STRUCT ENZYMOL MOL | 1 | 50% | 0.2% | 2 |
6 | IRPAS GRP | 1 | 100% | 0.2% | 2 |
7 | S CLIN IMMUNOL | 1 | 100% | 0.2% | 2 |
8 | INFECT IMMUN DIS MECH | 1 | 19% | 0.5% | 6 |
9 | AUTOIMMUNE GENOM ETIOL CAGE | 1 | 50% | 0.1% | 1 |
10 | BIOCHEM MOL MED NUTRIGENOM | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000123717 | C3 AND C4//COMPLEMENT AND INFLAMMATION//LUPUS EXCELLENCE |
2 | 0.0000105651 | RGC 32//RESPONSE GENE TO COMPLEMENT 32//BIIG |
3 | 0.0000096574 | MANNOSE BINDING LECTIN//MANNAN BINDING LECTIN//LECTIN PATHWAY |
4 | 0.0000086233 | C2 DEFICIENCY//COMPLEMENT GENETICS//COMPLEMENT AND INFLAMMATION |
5 | 0.0000083558 | COMPLEMENT RECEPTOR 1//COMPLEMENT RECEPTOR TYPE 1//CR1 |
6 | 0.0000080462 | CTRP3//CTRP 3//CTRP5 |
7 | 0.0000072156 | ATYPICAL HEMOLYTIC UREMIC SYNDROME//FACTOR H//C3 GLOMERULOPATHY |
8 | 0.0000067409 | COMPLEMENT SYNTHESIS//MRC TRANSPLANTAT TRANSPLANTAT IMMUNOL M//COMPLEMENTO |
9 | 0.0000060705 | MULTIVALENT IMMUNOTOXINS//KINETIC PARAMETERS OF BINDING//CHRONIC LYMPHOLEUKEMIA |
10 | 0.0000060446 | CALRETICULIN//CALNEXIN//CALNEXIN HOMOLOGUE |